First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 900 shares, a decline of 40.0% from the December 31st total of 1,500 shares. Based on an average daily volume of 2,300 shares, the days-to-cover ratio is presently 0.4 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 0.5 %

First Trust Nasdaq Pharmaceuticals ETF stock traded down $0.13 during mid-day trading on Friday, hitting $27.74. The company had a trading volume of 3,160 shares, compared to its average volume of 2,518. The stock has a market cap of $15.26 million, a price-to-earnings ratio of 15.98 and a beta of 0.70. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $25.73 and a 1 year high of $29.72. The business has a fifty day moving average of $27.46 and a 200 day moving average of $28.22.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently announced a dividend, which was paid on Tuesday, December 31st. Investors of record on Friday, December 13th were given a $0.1304 dividend. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date was Friday, December 13th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.